| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, Eleclazine, Nav1.5 channel inhibitor targeting SCN5A (Novartis, 71183216) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/71183216 |
| Similar Terms | |
| Downloads & Tools |
6 genes differentially expressed following the CB-75-PH34_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| FKBP1A | FK506 binding protein 1A, 12kDa | 2.31347 |
| RPL11 | ribosomal protein L11 | 0.566136 |
| RPL37 | ribosomal protein L37 | 0.55142 |
| CALU | calumenin | 0.319574 |
| THOC6 | THO complex 6 | 0.239452 |
| Symbol | Name | Standardized Value |
|---|---|---|
| ADAM19 | ADAM metallopeptidase domain 19 | -0.285344 |